Kidney injury in COVID-19
| Autor: | Peter J. Conlon, Chaudhry Adeel Ebad, Muniza Manshad Satti, Adeel Rafi Ahmed, Sinead Stoneman |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19) medicine.medical_treatment 030232 urology & nephrology Autopsy Review 030204 cardiovascular system & hematology Cytokine storm 03 medical and health sciences 0302 clinical medicine Epidemiology Medicine Renal replacement therapy Intensive care medicine Acute respiratory distress syndrome business.industry SARS-CoV-2 Incidence (epidemiology) Acute kidney injury COVID-19 medicine.disease Pathophysiology business |
| Zdroj: | World Journal of Nephrology |
| ISSN: | 2220-6124 |
| Popis: | Coronavirus disease 2019 (COVID-19) continues to affect millions of people around the globe. As data emerge, it is becoming more evident that extrapulmonary organ involvement, particularly the kidneys, highly influence mortality. The incidence of acute kidney injury has been estimated to be 30% in COVID-19 non-survivors. Current evidence suggests four broad mechanisms of renal injury: Hypovolaemia, acute respiratory distress syndrome related, cytokine storm and direct viral invasion as seen on renal autopsy findings. We look to critically assess the epidemiology, pathophysiology and management of kidney injury in COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|